
New Antibody Delivery Method Shows Promise Against Parkinson’s Protein
Israeli and U.S. scientists from Tel Aviv, Technion, and Cornell developed a new antibody delivery method showing promise against Parkinson's protein in nerve.

Israeli and U.S. scientists from Tel Aviv, Technion, and Cornell developed a new antibody delivery method showing promise against Parkinson's protein in nerve.
Galmed Pharmaceuticals has developed a brain-penetrating Aramchol formulation using nanotech, showing promise for Parkinson's and dementia treatments.

Israeli and U.S. scientists from Weizmann Institute and Washington University adapted CAR-T cancer therapy, pioneered by Prof. Selig Ashhar, to fight.

A new blood test developed by Israeli and British researchers offers a fast, affordable, and highly accurate tool to identify Parkinson’s disease in its earliest stages even before symptoms start to appear. Parkinson’s, a chronic, progressive neurodegenerative disorder, affects more than 10...